Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
-
Lotus Technology Reinforces ESG Commitment to its "Driving Change" Vision through 2023 Annual Report
-
Buckley Capital Management Urges Dentalcorp Holdings Board and Management to Undertake a Strategic Review Process
-
Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting
-
Abercrombie & Fitch Co. Reports First Quarter Fiscal 2024 Results
-
LeddarTech Announces Participation in the Maxim Group Virtual TMT Conference on June 4, 2024 and the Deutsche Bank Global Auto Industry Conference on June 11-12, 2024 in New York, NY
-
Cronos Group Inc. to Speak at Bernstein's 40th Annual Strategic Decisions Conference
-
Streamline Health® Announces New RevID™ Contract with 400-Bed Health System
-
Arbutus to Participate in Jefferies Global Healthcare Conference
-
Vyluma Announces Marketing Authorization Application Validation for the European Union
-
Invesco Ltd: Form 8.3 - International Paper Company
-
Howard Hughes Holdings Inc. to Present at NAREIT REITweek 2024 Investor Conference
-
Red Pine Intercepts Significant Mineralization at the Wawa Gold Project, including 5.58 g/t gold over 18.44 m including 72.20 g/t gold over 0.88 m
-
Draganfly to Present at Centurion One Los Angeles Summit 2024
-
Ocugen to Present at BIO International Convention 2024
-
The Habit Burger Grill Opens Second Lancaster Location in Home State of California
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion
-
Gildan Activewear Reports on Shareholders’ Voting Results
-
Sable Stakes Additional Ground Along the Perk Rocky Regional Trend in BC, Canada
-
Valore Update of Hatchet Lake Uranium Project
-
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
-
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
-
Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
-
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
-
ProKidney to Participate in the Jefferies Global Healthcare Conference
-
The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
-
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
-
Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
-
Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
-
Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
-
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
-
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
-
Cielo Announces Appointment of New Auditor
-
Athira Pharma to Participate in Upcoming June Conferences
-
Dragonfly Energy to Participate in June 2024 Conferences
-
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
-
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
-
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
-
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
-
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
-
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024
-
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
-
OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQX
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
